Patents by Inventor Andreas Zimmer

Andreas Zimmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100222438
    Abstract: Novel methods and pharmaceutical compositions suitable for modulating bone growth and remodeling, preventing bone diseases, inducing bone growth or repair by cannabinoid receptor-mediated effects on bone cells is disclosed. Methods of identifying bone growth modulating agents are also disclosed.
    Type: Application
    Filed: February 23, 2010
    Publication date: September 2, 2010
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Itai Bab, Raphael Mechoulam, Andreas Zimmer, Esther Shohami
  • Patent number: 7749953
    Abstract: Novel methods and pharmaceutical compositions suitable for modulating bone growth and remodeling, preventing bone diseases, inducing bone growth or repair by cannabinoid receptor-mediated effects on bone cells is disclosed. Methods of identifying bone growth modulating agents are also disclosed.
    Type: Grant
    Filed: December 6, 2004
    Date of Patent: July 6, 2010
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Itai Bab, Raphael Mechoulam, Andreas Zimmer, Esther Shohami
  • Publication number: 20100035101
    Abstract: In order to create a fuel cell unit, comprising a cathode-electrolyte-anode unit and at least one bipolar plate which is connected to an electrode of the cathode-electrolyte-anode unit in an electrically conductive manner, which has a low contact resistance between the bipolar plate and an electrode of the cathode-electrolyte-anode unit, it is suggested that the fuel cell unit comprise at least one electrically conductive intermediate element which is arranged between the bipolar plate and the electrode and has at least one contact surface facing the electrode.
    Type: Application
    Filed: September 3, 2009
    Publication date: February 11, 2010
    Inventors: Uwe Maier, Thomas Kiefer, Andreas Zimmer
  • Patent number: 7407753
    Abstract: The present invention uncovers a highly significant association of SNPs in the CNR2 locus, encoding the cannabinoid receptor 2 protein, with osteoporosis. Methods and kits for determining predisposition to osteoporosis, improving diagnosis in individuals suspected of having osteoporosis are provided. Also provided a method of identifying a putative osteoporosis-causing genetic mutation in a subject.
    Type: Grant
    Filed: May 24, 2004
    Date of Patent: August 5, 2008
    Assignees: Yissum Research Development Company of the HebrewUniversityofJerusalem, Institut National de la Sante et de la Recherche Medicale
    Inventors: Andreas Zimmer, Meliha Karsak, Marie-Christine De Vernejoul, Itai Bab, Esther Shohami, Raphael Mechoulam
  • Publication number: 20050260608
    Abstract: The present invention uncovers a highly significant association of SNPs in the CNR2 locus, encoding the cannabinoid receptor 2 protein, with osteoporosis. Methods and kits for determining predisposition to osteoporosis, improving diagnosis in individuals suspected of having osteoporosis are provided. Also provided a method of identifying a putative osteoporosis-causing genetic mutation in a subject.
    Type: Application
    Filed: May 24, 2004
    Publication date: November 24, 2005
    Inventors: Andreas Zimmer, Meliha Karsak, Marie-Christine De Vernejoul, Itai Bab, Esther Shohami, Raphael Mechoulam
  • Publication number: 20050137159
    Abstract: Novel methods and pharmaceutical compositions suitable for modulating bone growth and remodeling, preventing bone diseases, inducing bone growth or repair by cannabinoid receptor-mediated effects on bone cells is disclosed. Methods of identifying bone growth modulating agents are also disclosed.
    Type: Application
    Filed: December 6, 2004
    Publication date: June 23, 2005
    Inventors: Itai Bab, Raphael Mechoulam, Andreas Zimmer, Esther Shohami
  • Patent number: 6165988
    Abstract: The medicament in particulate form has one or more anionic or partially anionic active substances bound to a carrier material. The carrier material includes particulate copolymer or homopolymer of acrylic acid or acrylic acid ester or methacrylic acid esters. The carrier further includes oxygen in the ester group, a branched or unbranched alkyl chain with 2-10 carbon atoms, --NR.sub.2 where R represents H and lower alkyl chains in any combination, and H or a lower alkyl chain. The grain size distribution of the carrier is 10-1000 nm.
    Type: Grant
    Filed: August 11, 1997
    Date of Patent: December 26, 2000
    Assignees: Christian Noe, Joerg Kreuter
    Inventors: Christian Noe, Jorg Kreuter, Andreas Zimmer, Hans-Peter Zobel, Frank Stieneker, Serap Atmaca-Abdel Aziz